
Healthome
Personalized cancer care with expert health navigation and genomic science.
Date | Investors | Amount | Round |
---|---|---|---|
* | N/A | Seed | |
Total Funding | 000k |
Related Content
HealthŌme Inc., established in 2021, operates at the intersection of genomics and insurance, offering a precision health management platform. The company was co-founded by Darren Rowe and Ronen Santo, who serve as President and CEO, respectively. Their combined experience in the insurance and healthcare sectors underpins HealthŌme's strategic direction. The firm primarily partners with life and critical illness insurance carriers to embed its services into their policies.
The core of HealthŌme's business is to provide policyholders with early access to genomic health insights as a living benefit, aiming to enhance policyholder engagement and improve health outcomes. This is achieved through their proprietary platform which integrates advanced genomics, clinical data, and behavioral science. The business model appears to be B2B, where insurance carriers pay to incorporate HealthŌme's services into their offerings, thereby adding value to their policies and potentially improving persistency and mortality rates.
Policyholders who opt-in receive an at-home testing kit to collect a DNA sample. HealthŌme then analyzes this data to create a personalized health map, identifying predispositions to hereditary cancers and cardiovascular conditions. This information is delivered through a digital platform, supplemented by consultations with genetic counselors and clinical care coordinators to help individuals understand their results and develop personalized care plans. A key feature of their service is the continuous updating of these health maps as new genomic discoveries are made, ensuring the information remains relevant over time. Keywords: precision health, genomics, insurtech, life insurance benefits, critical illness insurance, genetic testing, personalized medicine, preventative healthcare, health management, DNA testing, hereditary disease screening, cancer risk assessment, cardiovascular health, policyholder engagement, living benefits, Darren Rowe, Ronen Santo, B2B healthcare, health data platform, clinical care coordination
Investments by Healthome
Edit